{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:30:48Z","timestamp":1793428248311,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2024-04103"],"award-info":[{"award-number":["RGPIN-2024-04103"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","award":["CRC-2024-00026"],"award-info":[{"award-number":["CRC-2024-00026"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Foundation for Support to Research of Minas Gerais State","doi-asserted-by":"publisher","award":["#RED-00196-23"],"award-info":[{"award-number":["#RED-00196-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Fondation canadienne pour l'innovation","doi-asserted-by":"publisher","award":["37324"],"award-info":[{"award-number":["37324"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Fondation canadienne pour l'innovation","doi-asserted-by":"publisher","award":["38858"],"award-info":[{"award-number":["38858"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Research Fund Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.talanta.2026.130703","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:20:55Z","timestamp":1790954455000},"page":"130703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Leishmania respiration profiling as a One Health functional marker associated with antimony resistance in human and canine leishmaniases"],"prefix":"10.1016","volume":"313","author":[{"given":"Ana Victoria","family":"Ibarra-Meneses","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Corbeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6727-1486","authenticated-orcid":false,"given":"Rafael","family":"Fernandes-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4429-0110","authenticated-orcid":false,"given":"David","family":"Langlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Rodrigues","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-2462","authenticated-orcid":false,"given":"Rubens L.","family":"do Monte-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-4956","authenticated-orcid":false,"given":"Christopher","family":"Fernandez-Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10151","key":"10.1016\/j.talanta.2026.130703_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.talanta.2026.130703_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009742","article-title":"Human leishmaniasis vaccines: use cases, target population and potential global demand","volume":"15","author":"Malvolti","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"10","key":"10.1016\/j.talanta.2026.130703_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14100970","article-title":"Overview of commercial vaccines against canine visceral leishmaniasis: current landscape and future directions","volume":"14","author":"Martiniano de Padua","year":"2025","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.talanta.2026.130703_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00353-5","article-title":"The status of combination therapy for visceral leishmaniasis: an updated review","volume":"24","author":"van Griensven","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"12","key":"10.1016\/j.talanta.2026.130703_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"4","key":"10.1016\/j.talanta.2026.130703_bib7","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"Ouellette","year":"2004","journal-title":"Drug Resist. Updates"},{"issue":"5","key":"10.1016\/j.talanta.2026.130703_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/0169-4758(93)90135-3","article-title":"Mechanisms of drug resistance in Leishmania","volume":"9","author":"Ouellette","year":"1993","journal-title":"Parasitol. Today"},{"issue":"21","key":"10.1016\/j.talanta.2026.130703_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1520693113","article-title":"Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania","volume":"113","author":"Gazanion","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.talanta.2026.130703_bib10","first-page":"13","article-title":"MRPA-independent mechanisms of antimony resistance in Leishmania infantum","author":"Douanne","year":"2020","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"12","key":"10.1016\/j.talanta.2026.130703_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005171","article-title":"Different mutations in a P-type ATPase transporter in leishmania parasites are associated with cross-resistance to two leading drugs by distinct mechanisms","volume":"10","author":"Fernandez-Prada","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.talanta.2026.130703_bib12","article-title":"Drug resistance analysis by next generation sequencing in Leishmania","volume":"5","author":"Leprohon","year":"2015","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.talanta.2026.130703_bib13","first-page":"102","article-title":"Exploring the paradox of defense between host and Leishmania parasite","author":"Kumari","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib14","doi-asserted-by":"crossref","DOI":"10.1042\/bj0370198","article-title":"A study of the excretion of organic antimonials using a polarographic procedure","volume":"37","author":"Goodwin","year":"1943","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.talanta.2026.130703_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.45.3.913-916.2001","article-title":"Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate","volume":"45","author":"Frezard","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"38","key":"10.1016\/j.talanta.2026.130703_bib16","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M405635200","article-title":"Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani","volume":"279","author":"Wyllie","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.talanta.2026.130703_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02360-16","article-title":"Meglumine antimoniate (Glucantime) causes oxidative stress-derived DNA damage in BALB\/c mice infected by Leishmania (Leishmania) infantum","volume":"61","author":"Moreira","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.talanta.2026.130703_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-026-07247-x","article-title":"Targeting mitochondrial bioenergetics: the \"Achilles' heel\" of Leishmania","volume":"19","author":"Sarkar","year":"2026","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.talanta.2026.130703_bib19","series-title":"Drug Discovery for Leishmaniasis","first-page":"402","article-title":"The redox metabolism and oxidative stress in Leishmania as a crossroads for the lethal effect of drugs","author":"Castro","year":"2017"},{"issue":"5","key":"10.1016\/j.talanta.2026.130703_bib20","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.9b00505","article-title":"Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors","volume":"6","author":"Tunes","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"5\u20136","key":"10.1016\/j.talanta.2026.130703_bib21","article-title":"Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis","volume":"20","author":"Miro","year":"2009","journal-title":"Vet. Dermatol."},{"issue":"11","key":"10.1016\/j.talanta.2026.130703_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081899","article-title":"Proteomic and genomic analyses of antimony resistant Leishmania infantum mutant","volume":"8","author":"Brotherton","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib23","article-title":"Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum","volume":"4","author":"Brotherton","year":"2014","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib24","doi-asserted-by":"crossref","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.talanta.2026.130703_bib25","first-page":"949","article-title":"Control of the leishmaniases","author":"World Health","year":"2010","journal-title":"World Health Organ. Tech. Rep. Ser."},{"issue":"1","key":"10.1016\/j.talanta.2026.130703_bib26","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182023001129","article-title":"Antimony resistance and gene expression in Leishmania: spotlight on molecular and proteomic aspects","volume":"151","author":"Madusanka","year":"2024","journal-title":"Parasitology"},{"issue":"12","key":"10.1016\/j.talanta.2026.130703_bib27","doi-asserted-by":"crossref","DOI":"10.3201\/eid2512.190164","article-title":"Canine leishmaniasis control in the context of one health","volume":"25","author":"Dantas-Torres","year":"2019","journal-title":"Emerg. Infect. Dis."},{"issue":"10","key":"10.1016\/j.talanta.2026.130703_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9100809","article-title":"One health approach to leishmaniases: understanding the disease dynamics through diagnostic tools","volume":"9","author":"Hong","year":"2020","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.talanta.2026.130703_bib29","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182016002031","article-title":"Evaluating drug resistance in visceral leishmaniasis: the challenges","volume":"145","author":"Hendrickx","year":"2018","journal-title":"Parasitology"},{"issue":"11","key":"10.1016\/j.talanta.2026.130703_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkv237","article-title":"Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome","volume":"70","author":"Hendrickx","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens15020220","article-title":"Differential susceptibility to antimony in strains and clinical isolates of Leishmania amazonensis from Brazil: in vitro and in vivo studies and implications for drug response and treatment failure","volume":"15","author":"de Sousa Agostino","year":"2026","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib32","article-title":"High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms","volume":"8","author":"Fernandez-Prada","year":"2018","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"1","key":"10.1016\/j.talanta.2026.130703_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/S1368-7646(98)80213-6","article-title":"ABC transporters in Leishmania and their role in drug resistance","volume":"1","author":"Ouellette","year":"1998","journal-title":"Drug Resist. Updates"},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003476","article-title":"Intrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis","volume":"9","author":"Monte-Neto","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib35","article-title":"Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum","volume":"6","author":"Gomez Perez","year":"2016","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"9","key":"10.1016\/j.talanta.2026.130703_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.83","article-title":"Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania","volume":"2","author":"Moreira","year":"2011","journal-title":"Cell Death Dis."},{"issue":"Pt 12","key":"10.1016\/j.talanta.2026.130703_bib37","article-title":"Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony","volume":"134","author":"Mandal","year":"2007","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.talanta.2026.130703_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes3040328","article-title":"Mitochondrial proteomics of antimony and miltefosine resistant Leishmania infantum","volume":"3","author":"Vincent","year":"2015","journal-title":"Proteomes"},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2013.06.006","article-title":"Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines","volume":"190","author":"Matrangolo","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.talanta.2026.130703_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-020-04397-4","article-title":"Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance","volume":"13","author":"Zheng","year":"2020","journal-title":"Parasites Vectors"},{"issue":"1","key":"10.1016\/j.talanta.2026.130703_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38221-1","article-title":"Translational reprogramming as a driver of antimony-drug resistance in Leishmania","volume":"14","author":"Gutierrez Guarnizo","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.talanta.2026.130703_bib42","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182010000077","article-title":"Central carbon metabolism of Leishmania parasites","volume":"137","author":"Saunders","year":"2010","journal-title":"Parasitology"},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib43","doi-asserted-by":"crossref","DOI":"10.1096\/fj.07-9254com","article-title":"Retooling Leishmania metabolism: from sand fly gut to human macrophage","volume":"22","author":"Rosenzweig","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.talanta.2026.130703_bib44","first-page":"130","article-title":"Survival of the fittest: how Leishmania evades drug therapy","author":"Wagner","year":"2025","journal-title":"Adv. Parasitol."},{"issue":"3","key":"10.1016\/j.talanta.2026.130703_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jobm.202400655","article-title":"Molecular mechanisms of cell death in Leishmania donovani induced by selected steroidal alkaloids","volume":"65","author":"Menpadi","year":"2025","journal-title":"J. Basic Microbiol."},{"issue":"2","key":"10.1016\/j.talanta.2026.130703_bib46","doi-asserted-by":"crossref","DOI":"10.7150\/ntno.81485","article-title":"Personalized biosensors for point-of-care diagnostics: from bench to bedside applications","volume":"7","author":"Chandra","year":"2023","journal-title":"Nanotheranostics"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026013597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026013597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:35:15Z","timestamp":1793424915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914026013597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":45,"alternative-id":["S0039914026013597"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130703","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmania respiration profiling as a One Health functional marker associated with antimony resistance in human and canine leishmaniases","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"130703"}}